# ARHGAP1

## Overview
ARHGAP1 is a gene that encodes the protein Rho GTPase activating protein 1, which is a member of the RhoGAP family. This protein functions as a GTPase-activating protein (GAP) that plays a pivotal role in the regulation of Rho family GTPases, including RHOA, RAC1, and CDC42. These GTPases are integral to various cellular processes such as cytoskeletal organization, cell migration, and cell cycle progression (Li2017ARHGAP1; Géci2023The). The ARHGAP1 protein is characterized by its RhoGAP domain, which is essential for its GTPase-activating activity, and Sec14 putative lipid-binding domains, which may facilitate interactions with lipid membranes (Bernards2003GAPs). Through its regulatory functions, ARHGAP1 is involved in maintaining cellular homeostasis and has been implicated in cancer progression, where it can act as either a tumor suppressor or promoter depending on the context (Li2017ARHGAP1; Géci2023The).

## Structure
The ARHGAP1 protein, also known as RhoGAP, p50RhoGAP, or Cdc42GAP, is characterized by the presence of specific domains crucial for its function. It contains a RhoGAP domain, which is essential for its GTPase-activating activity, allowing it to regulate Rho family GTPases (Bernards2003GAPs). Upstream of the RhoGAP domain, ARHGAP1 harbors Sec14 putative lipid-binding domains, which may play a role in its interaction with lipid membranes (Bernards2003GAPs). The protein shares approximately 35% sequence identity with the Drosophila CG6811 protein, indicating some level of evolutionary conservation (Bernards2003GAPs).

The structural studies of related RhoGAP proteins suggest that the catalytic domains are primarily alpha-helical, with conserved arginine residues playing a crucial role in catalysis by stabilizing transition states (Bernards2003GAPs). However, specific details on the primary, secondary, tertiary, or quaternary structures of ARHGAP1 are not provided in the available literature. There is also no detailed information on post-translational modifications or splice variant isoforms of ARHGAP1 in the context provided. The presence of these domains and the sequence identity with Drosophila proteins suggest a functional role in cytoskeletal dynamics and cellular signaling pathways.

## Function
ARHGAP1, a member of the RhoGAP family, plays a crucial role in regulating the Rho family of GTPases, which are involved in various cellular processes such as cytoskeletal organization, cell migration, and cell cycle progression. ARHGAP1 functions as a GTPase-activating protein (GAP) that inactivates Rho GTPases by converting them from their active GTP-bound state to an inactive GDP-bound state. This inactivation is essential for modulating signal transduction pathways that maintain cellular homeostasis (Li2017ARHGAP1).

In healthy human cells, ARHGAP1 is primarily active in the cytoplasm, where it influences cell shape and motility by regulating the dynamics of the cytoskeleton. By controlling the activity of Rho GTPases, ARHGAP1 plays a significant role in cell adhesion and motility, processes that are critical for normal cellular functions such as migration and invasion (Géci2023The). The protein's activity is crucial for maintaining the balance of cellular processes, ensuring proper cell cycle progression and preventing abnormal cell proliferation (Li2017ARHGAP1).

ARHGAP1's regulatory function is vital for normal development and cellular function, as it helps coordinate the complex signaling networks that govern cell behavior and tissue organization (Li2017ARHGAP1).

## Clinical Significance
ARHGAP1 plays a significant role in various cancers due to its involvement in cell migration and invasion. In Ewing sarcoma, miR-130b targets ARHGAP1, leading to the activation of a metastatic CDC42-PAK1-AP1 feedback loop. This interaction results in the downregulation of ARHGAP1, which is associated with increased metastatic potential and poorer survival rates in patients (Satterfield2017miR‐130b). In cervical cancer, ARHGAP1 acts as a tumor suppressor. Its overexpression inhibits cell proliferation, migration, and invasion, while its lower expression correlates with larger tumor size and lymphatic invasion (Li2017ARHGAP1). Conversely, in breast cancer, ARHGAP1 is associated with promoting metastasis. It inactivates Rho GTPases, which are crucial for cell adhesion and migration, thus facilitating the epithelial-mesenchymal transition and cancer progression (Géci2023The). The gene's expression levels and interactions are critical in determining its role as either a tumor suppressor or promoter, depending on the cancer type. These findings highlight the potential of ARHGAP1 as a therapeutic target in cancer treatment.

## Interactions
ARHGAP1, a Rho GTPase-activating protein, is involved in the regulation of Rho GTPases, including RHOA, RAC1, and CDC42, by converting them from their active GTP-bound form to an inactive GDP-bound form. This interaction is crucial for processes such as cell migration and adhesion, particularly during epithelial-mesenchymal transition (EMT) in cancer metastasis (Géci2023The). 

In breast cancer cells, ARHGAP1 interacts with these Rho GTPases, contributing to the weakening of cell-cell adhesion and promoting cell migration and invasion (Géci2023The). In Ewing Sarcoma, miR-130b targets ARHGAP1, leading to the activation of CDC42 and subsequent signaling cascades involving PAK1 and AP-1, which are important for metastasis (Satterfield2017miR‐130b). 

ARHGAP1 also interacts with p53 in myocardial cells, promoting apoptosis through the regulation of pro-apoptotic and anti-apoptotic proteins (Zhang2019Rho). Despite its proposed specificity for CDC42, some studies have shown that ARHGAP1 does not exhibit activity towards CDC42 but rather inactivates RAC1 more efficiently (Müller2018Spatial).


## References


[1. (Satterfield2017miR‐130b) Laura Satterfield, Ryan Shuck, Lyazat Kurenbekova, Wendy Allen‐Rhoades, Dean Edwards, Shixia Huang, Kimal Rajapakshe, Cristian Coarfa, Lawrence A. Donehower, and Jason T. Yustein. Mir‐130b directly targets arhgap1 to drive activation of a metastatic cdc42‐pak1‐ap1 positive feedback loop in ewing sarcoma. International Journal of Cancer, 141(10):2062–2075, August 2017. URL: http://dx.doi.org/10.1002/ijc.30909, doi:10.1002/ijc.30909. This article has 38 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/ijc.30909)

[2. (Géci2023The) Imrich Géci, Peter Bober, Eva Filová, Evžen Amler, and Ján Sabo. The role of arhgap1 in rho gtpase inactivation during metastasizing of breast cancer cell line mcf-7 after treatment with doxorubicin. International Journal of Molecular Sciences, 24(14):11352, July 2023. URL: http://dx.doi.org/10.3390/ijms241411352, doi:10.3390/ijms241411352. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms241411352)

[3. (Zhang2019Rho) Xuezhi Zhang, Jun Guan, Minglei Guo, Hongyan Dai, Shanglang Cai, Changyong Zhou, Yongbin Wang, and Qiaoji Qin. Rho gtpase‑activating protein 1 promotes apoptosis of myocardial cells in an ischemic cardiomyopathy model. Kardiologia Polska, 77(12):1163–1169, December 2019. URL: http://dx.doi.org/10.33963/kp.15040, doi:10.33963/kp.15040. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.33963/kp.15040)

[4. (Li2017ARHGAP1) Jun-ping Li, Yang Liu, and Yi-hua Yin. Arhgap1 overexpression inhibits proliferation, migration and invasion of c-33a and siha cell lines. OncoTargets and Therapy, Volume 10:691–701, February 2017. URL: http://dx.doi.org/10.2147/OTT.S112223, doi:10.2147/ott.s112223. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.2147/OTT.S112223)

[5. (Bernards2003GAPs) André Bernards. Gaps galore! a survey of putative ras superfamily gtpase activating proteins in man and drosophila. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1603(2):47–82, March 2003. URL: http://dx.doi.org/10.1016/s0304-419x(02)00082-3, doi:10.1016/s0304-419x(02)00082-3. This article has 79 citations.](https://doi.org/10.1016/s0304-419x(02)00082-3)

6. (Müller2018Spatial) Spatial Organization of Rho GTPase signaling by RhoGEF/RhoGAP proteins. This article has 3 citations.